The Latest Biotechnology / Pharmaceuticals Articles from Streetwise Reports

Biopharma's New Drug for COPD Likely to be Approved

Research Report
  ()
Characteristics of the Buy-rated company's lead candidate make it "an intriguing commercial prospect," noted an H.C. Wainwright & Co. report.
Tags: Biotechnology / Pharmaceuticals

PDUFA Date Coming Up for U.K. Biopharma

Research Report
  ()
The company has a commercialization plan in place and is preparing further for approval, noted a Canaccord Genuity report.
Tags: Biotechnology / Pharmaceuticals

Analyst Says Pharma Co. Has No True Competitor

Research Report
  ()
Verona Pharma Plc. recently is gearing up for a potential FDA approval of its twice-daily ensifentrine, according to a Jefferies & Co. research note.
Tags: Biotechnology / Pharmaceuticals

LA Biotech's Lower Revenue Will Be Short Lived

Research Report
  ()
While Ontrak Inc. may have had a loss in revenue in 2023, this will be short-lived, according to a Roth MKM research note.
Tags: Biotechnology / Pharmaceuticals

Biotech Co.'s Target Price Significantly Higher Than Current

Research Report
  ()
Biofrontera Inc. is currently trading at US$1.26, but has a target price of US$26, according to a Roth MKM research note.
Tags:  Biotechnology / Pharmaceuticals

NY Biotech Has Potentially Game Changing Anxiety Therapy

Research Report
  ()
Mind Medicine (MindMed) Inc. recently announced positive results from its Phase 2b trial of MM120 in generalized anxiety disorder, according to a Roth MKM research note.
Tags:  Biotechnology / Pharmaceuticals

Leadership Cuts Won't Slow This Biotech

Research Report
  ()
While three executive officers have been cut from Kronos Bio Inc., it is still a Buy, according to an H.C. Wainwright & Co. report.
Tags:  Biotechnology / Pharmaceuticals

Pharma Co. Primed for Future Business

Research Report
  ()
Analysts at Research Capital believe that Knight Therapeutics Inc. is primed to conduct future business development.
Tags:  Biotechnology / Pharmaceuticals

Healthcare Co. Exceeds Expectations in Performance

Research Report
  ()
Sensus Healthcare Inc. released fourth-quarter financials that surpassed expectations, according to an H.C. Wainwright & Co. research note.
Tags:  Healthcare ServicesBiotechnology / Pharmaceuticals

Biotech Co.'s Sales Could Grow To US$310 Million in 2028

Research Report
  ()
Biotech Valneva SE announced that it had dosed the first participant in a Phase 2 pediatric trial evaluating its chikungunya vaccine candidate, according to an H.C. Wainwright & Co. report.
Tags:  Biotechnology / Pharmaceuticals

Boston Biotech Could Have Blockbuster Sales

Research Report
  ()
Tango Therapeutics may have "blockbuster potential," noted an H.C. Wainwright & Co. report.
Tags:  Biotechnology / Pharmaceuticals

California-Based Pharma Co.'s Progress Offers Upside

Research Report
  ()
While H.C. Wainwright & Co. lowered their price target, they still see upside for this pharmaceutical company.
Tags:  Biotechnology / Pharmaceuticals

Co.'s Breast Cancer Therapy Shows Encouraging Activity

Research Report
  ()
BriaCell Therapeutics Corp.'s lead targeted cell therapy, when combined with the PD-1 inhibitor retifanlimab, achieved an exceptional 71% intracranial objective response rate treating brain metastases in advanced breast cancer patients, according to an H.C. Wainwright report.
Tags:  Biotechnology / Pharmaceuticals

Biotech Secures Additional Funding, Extending Cash Runway

Research Report
  ()
Recently, Vera Therapeutics Inc. announced it had further strengthened its balance sheet by drawing down US$25 million in debt, bringing total cash reserves to US$159.9 million, noted H.C. Wainwright & Co.
Tags:  Biotechnology / Pharmaceuticals

Biotech Bolsters ADC Pipeline Through Atreca Asset Buy

Research Report
  ()
Biotech Immunome Inc. recently announced a purchase agreement with Altreca, noted Wedbush.
Tags:  Biotechnology / Pharmaceuticals

US Biotech's Anti-Fungal Wins European Approvals

Research Report
  ()
Recently, Cidara Therapeutics Inc. secured European Commission (EC) approval for its lead anti-fungal candidate Rezafungin to treat invasive candidiasis infections in adults, noted H.C. Wainwright & Co.
Tags:  Biotechnology / Pharmaceuticals

Biotech Co. Reports Encouraging ALS Data but FDA Wants More

Research Report
  ()
Salt Lake City-based Clene Inc. reported both encouraging clinical data and a regulatory setback for its ALS drug candidate CNM-Au8, reported Roth MKM.
Tags:  Biotechnology / Pharmaceuticals

Pharma Co. May Have Accelerated FDA Approval in 2024

Research Report
  ()
TRACON Pharmaceuticals Inc. provided an update on enrollment progress for their ongoing Phase 2 ENVASARC clinical trial testing the drug envafolimab to treat sarcoma, reported H.C. Wainwright & Co.
Tags:  Biotechnology / Pharmaceuticals

Bioscience Co. Expands Collaboration

Research Report
  ()
This bioscience company's price target implies 680% upside, according to a Roth MKM report.
Tags:  Biotechnology / Pharmaceuticals

Texas Biotech Advances Lead Candidate in Resistant AML

Research Report
  ()
Recently, Texas-based biotech Bio-Path Holdings Inc. announced it had completed the first safety cohort of a Phase 1/1b trial evaluating the developmental drug BP1002 in acute myeloid leukemia (AML). Read on to see what one Roth analyst has to say about the company's stock.
Tags:  Biotechnology / Pharmaceuticals

Biotech Seeks Approval of Synthetic Blood Vessel Graft

Research Report
  ()
Humacyte Inc. announced the submission of a Biologics License Application (BLA) to the FDA seeking approval for its lead product candidate Human Acellular Vessel (HAV), noted H.C. Wainwright & Co. Analyst Vernon Bernardino.
Tags:  Biotechnology / Pharmaceuticals

Antibodies from Vaccine Remain Two Years Out

Research Report
  ()
This was shown in recent clinical trial results of a biotech's single-dose vaccine against chikungunya evaluated in adults, noted an H.C. Wainwright & Co. report.
Tags:  Biotechnology / Pharmaceuticals

Drugs Show Anti-Cancer Effects on Myeloma Cells

Research Report
  ()
These positive results bode well for the biopharma's two polyamine inhibitors as potential treatments for multiple myeloma, noted a ROTH Capital Markets report.
Tags:  Biotechnology / Pharmaceuticals

Pharma Co. Reports Positive Data for Leukemia Combination Therapy

Research Report
  ()
Recently, Syros Pharmaceuticals Inc. announced positive data for its Leukemia Combination Therapy, noted an H.C. Wainwright & Co. report.
Tags:  Biotechnology / Pharmaceuticals

Pharma Co.'s Partnership a Key Validation

Research Report
  ()
Recently, Arcus Biosciences Inc. announced a partnership with Exelixis Inc., which may be the key to validating the company, noted WedBush analysts in a December 4 report.
Tags:  Biotechnology / Pharmaceuticals

Showing Results: 1 to 25 of 37 Next